Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00582634 · ClinicalTrials.gov registry record · Phase 2

Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer

A Phase 2 study of Non-Small Cell Lung Cancer, sponsored by University of Wisconsin, Madison.

Completed
Registry status
Phase 2
Development phase
4
Enrollment target
1
Study location

NCT00582634: Completed Phase 2 study of Non-Small Cell Lung Cancer, sponsored by University of Wisconsin, Madison.

NCT00582634 is a Phase 2 study of Non-Small Cell Lung Cancer that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 4 participants, below the 652-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00582634, a Phase 2 study of Non-Small Cell Lung Cancer, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
Phase 2
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

* To determine if docetaxel and cisplatin can be administered in a dose intense manner in the adjuvant setting in resected non-small cell lung cancer * To evaluate the time to progression and overall survival * To evaluate toxicities of this chemotherapy combination in the adjuvant setting * To correlate XPD and ERCC1 polymorphisms with time to progression and toxicities in patients treated with this regimen

Conditions Studied

Non-Small Cell Lung Cancer

Interventions

  • DRUG docetaxel and cisplatin

Study Locations (1)

Wisconsin

  • University of Wisconsin Comprehensive Cancer Center - Madison

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2004-09
Est. Completion 2007-12
Phase Phase 2
University of Wisconsin, Madison

1,039 total trials

What the finished NCT00582634 record still lists

NCT00582634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 652-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which docetaxel and cisplatin is the first listed.

NCT00582634 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00582634 about?

NCT00582634 is a clinical study titled "Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer". * To determine if docetaxel and cisplatin can be administered in a dose intense manner in the adjuvant setting in resected non-small cell lung cancer * To evaluate the time to progression and overall survival * To evaluate toxicities of this chemotherapy combination in the adjuvant setting * To corr...

What is the current status of trial NCT00582634?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2004-09. Estimated completion is 2007-12.

What conditions does trial NCT00582634 study?

This clinical trial studies the following conditions: Non-Small Cell Lung Cancer.

What interventions are being tested in trial NCT00582634?

The interventions under investigation include: docetaxel and cisplatin (DRUG).

Who is sponsoring clinical trial NCT00582634?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00582634 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Non-Small Cell Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00582634's enrollment target sits among peer trials

4 454th of 454 higher than 1 of 454 other Non-Small Cell Lung Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Non-Small Cell Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00582634, the US trial registry maintained by the National Library of Medicine. NCT00582634 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.